Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04198012 · ClinicalTrials.gov registry record · NA
An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System
A NA study, sponsored by Deka Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04198012 is a NA study that has completed, run by Deka Research and Development. The registered enrollment target is 25 participants.
The verdict
NCT04198012, a NA study, has completed, sponsored by Deka Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study is designed to monitor and assess the safety of continued access to the HemoCare™ Hemodialysis System used during the review of the pre-market notifications for the devices in the HemoCare™ Hemodialysis System.
Interventions
- DEVICE HemoCare™ Hemodialysis System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2024-04-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04198012
The ClinicalTrials.gov registry entry for NCT04198012 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Deka Research and Development, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HemoCare™ Hemodialysis System is the first listed.
NCT04198012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04198012 about?
NCT04198012 is a clinical study titled "An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System". This study is designed to monitor and assess the safety of continued access to the HemoCare™ Hemodialysis System used during the review of the pre-market notifications for the devices in the HemoCare™ Hemodialysis System.
What is the current status of trial NCT04198012?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-12-16. Estimated completion is 2024-04-05.
What interventions are being tested in trial NCT04198012?
The interventions under investigation include: HemoCare™ Hemodialysis System (DEVICE).
Who is sponsoring clinical trial NCT04198012?
This trial is sponsored by Deka Research and Development, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.